Sherry Deren1*
Tara Cortes2
Victoria Vaughan Dickson2Vincent Guilamo-Ramos3Benjamin H. Han4
Stephen Karpiak5Madeline Naegle2Danielle C. Ompad1Bei Wu2- 1Center for Drug Use and HIV Research, College of Global Public Health, New York University, New York, NY, United States
- 2Rory Meyers College of Nursing, New York University, New York, NY, United States
- 3Silver School of Social Work, New York University, New York, NY, United States
- 4Department of Medicine, New York University Langone Health, New York, NY, United States
- 5Gay Men's Health Crisis, AIDS Community Research Initiative of America Center on HIV and Aging, New York, NY, United States
Older people living with HIV (OPLWH) have higher rates of substance use (tobacco, alcohol, and other drugs) than their HIV-negative peers. Addressing health care needs of OPLWH who use substances is more challenging than for those who do not: they are highly impacted by comorbid conditions, substance use can interact with other medications (including antiretroviral therapy-ART) and reduce their effectiveness, and substance use has been associated with reduced adherence to ART and increased risky behaviors (including sexual risks). People who use substances also suffer disparities along the HIV continuum of care, resulting in lower viral suppression rates and poorer health outcomes. They are especially impacted by stigma and stress, which have implications for HIV treatment and care. Recommendations for health care providers working with OPLWH who use substances include: (1) the need to screen and refer for multiple associated conditions, and (2) training/continuing education to enhance care management and maximize health outcomes.
Introduction
As treatments for HIV have improved, the population of older people living with HIV (OPLWH) has increased. In 2015 it was estimated that more than 47% of those living with HIV were aged 50 and older, and 7% were 65 and older (1). The proportion of adults living with HIV aged 50 and older increases by an average of 2% annually (2), and 17% of new infections are among people aged 50 and older (1).
Aging and HIV are each associated with a broad range of comorbidities and treatment needs. Addressing the health care needs of OPLWH who use substances, including tobacco, alcohol, and other drugs, is even more challenging than for those who do not use these substances. These challenges come from several sources: OPLWH who use substances are highly impacted by comorbid conditions and substance use can interact with other medications including anti-retroviral therapy (ART) reducing their effectiveness or resulting in unanticipated side-effects. In addition, while some research indicates that OPLWH are more adherent to ART than younger populations living with HIV (3), HIV-infected people who use substances may be less adherent to ART, and suffer disparities all along the continuum of care including lower retention in care, delayed initiation of ART and poorer HIV treatment outcomes (4).
OPLWH have higher rates of substance use than their HIV-negative peers (5). In addition, while rates of substance use largely decline with increasing age in the general population, this has not been found among OPLWH (6). Thus, as the population of those who are HIV-infected continues to age, there is a need for health care providers, especially those working with geriatric populations, to become knowledgeable about the impact of substance use on OPLWH so that their health care needs are optimally identified and addressed.
The authors of this article represent several disciplines, including nursing, psychology, gerontology, social work and epidemiology, and bring multiple perspectives to research and practice. The article will provide an overview of substance use prevalence among OPLWH who are aged 50 and older and many of the comorbidities and associated challenges encountered in managing their health needs. The importance of addressing psychosocial factors and sexual risk behaviors among substance-using OPLWH are also discussed. A final section provides recommendations for screening for the needs of OPLWH and for associated training needs of health care professionals working with them.
Prevalence of Substance Use Among OPLWH
Surveying 1,000 older adults (aged 50 and older) living with HIV in New York City, the ROAH(Research on Older Adults with HIV) study (7) found that more than half (54%) of the participants were actively enrolled in recovery programs and over one-third reported current (past 3 months) use of illicit substances (37%) or alcohol (38%). Prevalence of specific substances was: tobacco (57%), marijuana (23%), pain killers (38%) cocaine (15%), and heroin (7%) (8). Alcohol is the most frequently used substance among OPLWH (9). Other studies have shown substance use prevalence rates (excluding alcohol) of over 50% in OPLWH (10). Importantly, while injection drug use as a transmission category for HIV has declined in incidence, accounting for 9% of new HIV cases in the US in 2016, it constitutes approximately 18% of people living with HIV (11).
The high rate of substance use among OPLWH is likely to continue. As the baby boomer generation ages, due to their greater experience with mood-altering substances, they use higher levels of alcohol and other substances than previous generations (12).
Men Who Have Sex With Men
Men who have sex with men (MSM) account for more than half of all people living with HIV (54%) and about 70% of new infections (13). It has been widely documented that MSM are more likely to use illicit drugs as compared to their heterosexual counterparts (14, 15). About one-third of new HIV infections among MSM have been attributed to risk behaviors related to non-injection substance use (including the use of alcohol and other drugs before having sex) (16).
In the ROAH study (7), 53.0% of HIV-positive MSM aged 50 and older in NYC reported alcohol use, 21.4% reported using poppers (i.e., nitrite inhalants), 22.9% reported “hard” drug use (i.e., crystal methamphetamine, cocaine, crack, heroin, ecstasy, GHB, ketamine, and/or LSD/PCP), and 28.0% reported marijuana use. In a more recent study of HIV-positive MSM aged 50 years and older, 48.2% had used an illicit drug in the past 30 days (17).
Tobacco and Alcohol
Alcohol and tobacco are not always included in studies of substance use, in part because of their legal status. However, because of their widespread use and significant adverse impacts on OPLWH, they are covered in more specific detail below.
Tobacco
Smoking is a major risk factor for a variety of life-threatening chronic diseases such as coronary heart disease, diabetes, and cancer (18). Smoking is also a source of inflammation and impaired immune function (19). The health impacts of smoking are of particular concern among people living with HIV, as they are almost twice as likely to smoke than the national average (42.4 vs. 20.6%), are less likely to quit (20) and already have compromised immunity and a predisposition for chronic inflammation (21). Furthermore, adults with HIV who smoke are more likely to be poor, homeless, previously incarcerated, depressed, and have lower educational attainment than those who do not smoke (20), and thus have multiple risk factors for poor health outcomes.
Smoking has been shown to increase the incidence of both AIDS and non-AIDS-related mortality (21, 22). HIV and smoking serve as independent and interacting risk factors for serious conditions such as cardiovascular disease, chronic obstructive pulmonary disease (COPD), human papillomavirus (HPV), and related cancers (21). In addition, smoking may have indirect adverse effects on health by lowering ART adherence (mediated by depressive symptoms) (23), and reducing the effectiveness of ART medication (24, 25). In older adults, smoking may also increase the likelihood of fractures by further decreasing bone mineral density already diminished by the effects of HIV and ART (21, 26).
Alcohol
Heavy alcohol use contributes to hypertension, liver disease, cancers, cardiac dysrhythmia, gastrointestinal problems, neurocognitive deficits, bone loss, depression, and impaired judgment leading to risky behaviors (27, 28). Other consequences include suicide, child maltreatment, and unsafe sex and drug injection practices associated with HIV (29, 30). Furthermore, OPLWH are more susceptible to the negative effects of alcohol use, as tolerance lowers with age, metabolism slows, and interaction with prescription medications may impact the effectiveness of medications or exacerbate side effects (31). The prevalence of alcohol use disorders is higher among people living with HIV than the national average (32), and there is higher morbidity and mortality at lower levels of alcohol consumption among HIV-positive individuals compared with those who are HIV-negative (33).
Alcohol has been found to have an impact on HIV disease severity and mortality (9). Heavy alcohol consumption, HIV, and aging independently increase the risk for several comorbidities including cardiovascular disease, liver cirrhosis, diabetes pneumonia and myopathy (34), hypertension and impaired renal function (35). Furthermore, heavy alcohol use among HIV positive people has been linked with reduced engagement at every stage of the HIV care continuum, resulting in increased viral loads, and faster disease progression (36). There is also some conflicting evidence for interactions between alcohol and ART which may reduce ART efficacy, for example by disrupting membrane transporter proteins for some ART medications (37).
Overall, there is a high rate of substance use among OPLWH, and this is related to comorbidities and disease progression. Thus, efforts to screen for substance use and address its consequences are essential in the care of OPLWH.
Co-Morbidities of OPLWH
OPLWH have a higher number of comorbidities than is found in their non-infected age counterparts (38, 39). In the ROAH study (7), depression was the most common comorbidity, and 40% of participants reported 4 or more comorbidities, with an average of 3.3, about three times higher than seen among community dwelling adults 70 years and older (40). A recent review article (41) noted that among OPLWH, complications associated with aging can appear clinically in essentially every organ system. Vance (42) found that in OPLWH who were >60 years old, 20.5% had coronary artery disease, 67.1% had hypertension, 65.8% had hyperlipidemia, 28.8% had diabetes, 24.7% had peripheral neuropathy, 23.3% had renal disease, 12.7% had hepatitis C, and 38.4% had depression with the success of ART, OPLWH are dying from non-AIDS related conditions more often than AIDS-related conditions (43). Accelerated or accentuated aging has been proposed among OPLWH and attributed as a cause of higher frequencies of co-morbidities (44).
The multimorbidity found among OPLWH has been attributed to several causes, including: (1) the impact of chronic HIV infection (44); (2) behavioral factors related to substance use; (3) elevated rates of inflammation and immune activation (45); and (4) the higher toxicity of early forms of ART (46). Few studies have the power to control for the many variables that contribute to this high rate of multimorbidity in OPLWH (47).
Polypharmacy and Adherence
The high rates of multimorbidity among OPLWH result in increased pill burden and disease management (42, 48). Polypharmacy has been associated with side effects, drug interaction, and challenges to adherence (49). In one study, OPLWH who were in their 50s were prescribed an average of 12.5 medications (42).
While higher numbers of medications are associated with greater odds of having a fall requiring medical attention for older populations, this is further exacerbated for those with substance use disorders (50). In addition, there are several shared cytochrome enzymes in the metabolism of antiretroviral medications with different substances including alcohol, cocaine, opioids, and marijuana. Therefore, drug-drug interactions between antiretroviral medications and substance use through cytochrome enzymes could decrease the efficacy of antiretroviral therapy, thereby worsening HIV-related outcomes (51).
Many studies have reported relationships between substance use and non-adherence to medications (52) including non-adherence to ART (53). For example, one study of OPLWH examined the relationship between ART non-adherence (number of days when ART was skipped) and days when study participants used alcohol, marijuana, cocaine/crack, opiates, amyl nitrite (poppers), and other drugs. The best adherence (92% reported >90% adherence) was among those reporting no substance use, and the poorest ART adherence was among those reporting polydrug use (<65% reporting >90% adherence) (10).
Geriatric Conditions
As OPLWH age, there is evidence of an increased burden of age-related chronic conditions (44). These geriatric conditions (or syndromes) have distinguishing features that set them apart from other health conditions—they effect multiple organ systems and are influenced by environmental factors. These conditions are common among vulnerable populations including adults with comorbidities (as is frequently found in OPLWH), and are typically followed by a decline in functional health (54). Common geriatric conditions include falls, cognitive impairment, urinary incontinence, delirium, and frailty (54). The recognition and management of geriatric conditions is critical because they are independently associated with functional decline and mortality (55). When geriatric conditions are addressed, the health status of older adults improves, particularly for vulnerable populations. This is evidenced by decreasing mortality risks, nursing home admissions, and acute care utilization (56, 57). Geriatric conditions are common among OPLWH, including cognitive impairment, falls, urinary incontinence, and difficulty with 1 or more instrumental activities of daily living (58). The recognition and treatment of geriatric conditions in OPLWH should be incorporated into HIV care (59).
Attention to geriatric conditions is particularly relevant for substance-using OPLWH. Problems associated with prolonged substance use and substance use-related comorbidities and behaviors have been linked to accelerated rates of frailty (60, 61). Drug use has a wide array of physiologic effects on the body that may place OPLWH at heightened risk for geriatric conditions. Substance use itself can impact geriatric conditions directly as excess or harmful alcohol use, prescription opioid use, and benzodiazepine use have all been associated with an increase in falls and cognitive changes (60, 62). A recent paper posited the impact of drug addiction on early onset of age-related disease, through toxicity and lifestyle factors (63).
Cognitive Functioning
Advanced age increases susceptibility to HAND (HIV-associated neurocognitive disorder) in HIV-infected persons, and it is estimated that about 50% of all ART patients present with cognitive impairment (64). Substance use has an impact on CNS structures related to cognitive function. For example, an escalated pattern of cocaine intake is associated with long-lasting damage to the prefrontal cortex, thus affecting cognitive function including executive function, attention, and memory (65). Additionally, stimulant drugs including amphetamine, cocaine, methamphetamine, and ecstasy impact on adult hippocampal neurogenesis. Exposure to stimulant drugs has an effect on neurogenesis regulation in adult brains which can result in drug-induced impairment in cognitive function (66).
Chronic substance use has been shown to lead to impaired cognitive performance. Relationships that have been identified include the following: (1) cocaine affects long-lasting memory (67); (2) amphetamine use is related to attention and impulse control (68); (3) opioids impact attention and performance on memory tasks (69); (4) alcohol affects working memory and attention (70); (5) cannabis impacts cognitive shifting and sustained attention (71); and (6) nicotine has been shown to have an impact on working memory and sustained attention (72).
The manifestations of the cognitive impairments depend on many factors including the types and frequency of substance use, the individual's genetic makeup, age, and environmental factors. The persistence of substance use over time is associated with long-lasting cognitive decline, a particular concern for OPLWH. For example, long-term cannabis users reported having more deficits on memory and sustained attention than short-term users (73). A study of ex-ecstasy abusers found persistent relatively poor score in verbal memory over 2.5 years of abstinence (74). In another study, persons with polysubstance dependence (cocaine or heroin) had deficits in executive function over 5 months of abstinence (75).
The multiple comorbidities found in OPLWH are related to HIV status and aging and impact many organ systems as well as psychiatric conditions such as depression and impairments in cognitive functioning. Thus, care for OPLWH requires a multidisciplinary team and holistic approach.
Psychosocial Influences on OPLWH Who Use Substances
Psychosocial influences have also been shown to have significant impact on health outcomes of OPLWH. Two important influences on the health of all HIV-infected populations that have been especially prevalent among people who use substances are stigma and stress/trauma.
Stigma
Stigma has been associated with HIV since early in the epidemic (76) and continues in the post-ART era (77). Emlet (78) noted that OPLWH contend with stigma related to ageism, including social discrimination from their peer networks and employment situations, and institutional/structural discrimination from health care providers.
Older adults who are members of sexual minorities fear rejection and neglect from health care providers, especially non-professional workers. In one study, 83% cited rejection by neighbors in their communities, as well as observations of rejection of partners and friends in long term care (79).
Some of the more recent literature on stigma notes the intersectionality of stigmas (80), i.e., stigma experienced on the basis of multiple characteristics, such as HIV status, older age, racial minority status, gender identity, real or perceived substance use and for MSM, stigma based on their sexuality. For example, intersectional stigma was identified in a study of older Black women living with HIV, who reported stigma related to gender, race, age, and disease (81).
Stigma has been found to be related to poorer health behaviors for PLWH (82, 83), including lower levels of adherence to ART, and lower usage of health and social services. Stigma also impacts disclosure and self-esteem among OPLWH (83). Interventions or factors found to help coping with stigma include social support (80) and spirituality (84).
Stress and Trauma
Early childhood abuse and PTSD has been associated with subsequent substance use, risky behaviors, and HIV (85, 86). For example, Lee (87) found that among a sample of people who inject drugs, almost one-third (30.9%) reported childhood sexual abuse, and this was associated with syringe sharing. In addition, many people who use substances have experienced poverty, homelessness, or incarceration, with resultant exposure to chronic and acute stressful life events. Minority stress related to sexual orientation has been related to increased substance use (88). Several pathways leading from stress and trauma to substance use and risky behaviors have been proposed (e.g., depression) and trauma-informed therapy for substance users has been recommended (89).
Risky Sexual Behavior
Many older adults remain sexually active well into their 7th−9th decades of life (90) and OPLWH have been shown to continue to engage in sexual behavior (91, 92). In the ROAH study, 40% of OPLWH reported engaging in anal or vaginal sex in the prior 3 months, and 75% of those sexually active reported having sex more than 2–3 times per month (91). Importantly, almost half of those who were sexually active reported having unprotected anal or vaginal sex in the past 3 months and about 21% of participants reported recent unprotected sex with HIV-negative partners or partners whose HIV status was unknown. Those who were sexually active were more likely to report recent drug use. Further, many studies have shown that substance use is related to risky sexual behaviors, e.g., condomless anal sex among HIV+ MSM (93), and risky sexual behaviors among HIV-infected MSM and women (94). Sexual risk may also vary with partner type. One study of OPLWH found that substance use was related to increased condomless sex with casual partners but not with main partners (95).
Similar to their younger peers, drug use by older adults with HIV is a prime predictor of engagement in high-risk sexual behavior and non-adherence to medications (96, 97). Poor adherence to ART is of concern for the health of the infected patient, and in addition, the resultant high viral loads increase the probability that HIV can be transmitted to sexual partners.
Substance use has been associated with greater sexual risk among MSM, but it is unclear whether sexual risk differs between older and younger MSM (98). In the ROAH Study, erectile dysfunction drugs and poppers were both associated with increased odds for condomless anal/vaginal sex among HIV-positive bisexual and gay men (99). There is some evidence to suggest that cognitive functioning may be an important factor to consider in the association between substance use and sexual risk behavior. In a study of older HIV-positive MSM, drinking to intoxication and current illicit substance use were associated with condomless anal sex when controlling for impairment on two or more cognitive tests, marijuana use, lifetime illicit substance use and HIV diagnosis on or before 1996 (93).
In addition to addressing substance use and co-morbidities of OPLWH, attention to psychosocial factors such as experiences of stigma and stress can also enhance their health status. Sexual health discussions with care providers can serve to reduce risks for both the OPLWH and their sex partners.
Recommendations for Care Providers
As part of their HIV care, many OPLWH are screened and treated for the co-morbidities identified in this paper, especially non-communicable diseases. However, screening may not be consistent across all patient groups, and as many OPLWH move into geriatric care environments, some important comorbidities, particularly substance use disorders, may be missed. Specific recommendations related to the care of OPLWH who are substance users include patient screening needs and staff training requirements. These are outlined in the following section.
Screening for Smoking and Providing Cessation Counseling
Many of the risks associated with tobacco use can be reduced by cessation, e.g., bacterial pneumonia in people living with HIV (100). In addition, the time since an HIV-positive individual has abstained from smoking is inversely correlated with risk for cardiovascular disease (101). One study showed that for those over 50 who stop smoking, smoking-related cardiovascular disease risks excess vanishes within 5 years after smoking cessation (102). Smoking cessation is a crucial intervention for promoting positive health outcomes among people living with HIV, especially OPLWH. Multiple interventions have been used for smoking cessation in this population, with varying degrees of success (103). Recommendations for the role of health care providers include the use of a brief intervention which consists of: routinely asking patients about tobacco use and their willingness to stop smoking, efforts to increase motivation to quit, and a range of cessation strategies such as providing nicotine substitution, and referral to stop smoking clinics (102).
Screen for Alcohol and Other Substance Use
The US Preventative Services Task Forces recommends screening all adults for alcohol misuse (104). The National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines low risk drinking as 1 drink per day (or 7 per week) and no more than 3 drinks per single day for men and women over 65 (105). OPLWH are encouraged to limit or abstain from alcohol consumption. Those with positive screening scores for misuse, hazardous or binge drinking (4 drinks for women and 5 drinks for men in about 2 h) should receive brief behavior counseling. The components of SBIRT (screening, brief intervention, and referral to treatment) provide an integrated approach to screening and intervention (106) and can be undertaken by physicians, nurses, or ancillary care providers (107). A positive score on the screener supports a brief intervention, where information about potential health risks based on the pattern of use is provided. Patients assessed with the likelihood of a moderate to severe substance use disorder should be referred to specialty treatment. This model has yielded positive outcomes across a range of health care settings and patient populations (106). Several screening tools are recommended for use with SBIRT, including computer-assisted self-interview instruments (108).
Assess for Depression and Other Mental Health Comorbidities
Depression is the most frequent comorbidity among OPLWH (7) and is one of the most underdiagnosed conditions in aging populations (109). Symptoms of clinical depression can be exacerbated in the presence of chronic conditions such as HIV (110). The validity of the Patient Health Questionnaires has been studied in primary care settings and with older adults (111, 112). Screening for stress and trauma should also be considered, as they are associated with substance use.
Assess for Geriatric Conditions Including Cognitive Deficits
Best practices for addressing geriatric conditions or syndromes is the prevention of geriatric conditions using an interprofessional team knowledgeable in caring for older adults. For example, preventing falls and reducing polypharmacy can prevent the emergence of associated geriatric conditions. Assessment of risk for geriatric conditions, therefore, is a component of integrated care. The Montreal Older Adults Cognitive Assessment (MOCA) is a brief, culturally sensitive tool that has been used extensively with persons with co-occurring chronic medical conditions. It has high sensitivity and specificity for mild cognitive impairment and Alzheimer's dementia (113). Cognitive assessment can provide data to the clinician about the severity of impairment related to NCDs, capacity for psychosocial interaction and the type of health teaching that may be useful in enhancing adherence, reducing risk behaviors, and better health practices generally.
Screen for Risky Sexual Behavior
Care providers are often uncomfortable discussing sexual intimacy, especially with older populations. The frequency of sexual health discussions between physicians and older patients has been found to be suboptimal (114), perhaps due to discomfort on the part of the health care provider or the assumption that people over the age of 65 are not sexually active. It is important for care providers to ask their patients who are OPLWH (as well as their other older patients) about their sexual behaviors and discuss the need for protection, review condom use skills, and provide condoms. This can also provide patients the opportunity to discuss their questions and concerns about various sexual activities. For OPLWH who are active with HIV-negative or HIV status-unaware sexual partners, PrEP (pre-exposure prophylaxis) should be raised as a prevention tool. Discussion of efforts to end HIV transmission and the campaign U = U (undetectable = untransmittable) can also inform this discussion. Further, exploration of other aspects of sexual health beyond HIV prevention can also be raised for the holistic care of OPLWH.
Provide Access to Drug Treatment and Harm Reduction Services
There are a wide array of evidence-based treatments available for people who use substances. These include medications for smoking [Chantix, Habitrol, Nicorette (115)], alcohol [naltrexone(Vivitrol), Acamprosate, Disulfiram (116)] and for prescription opioid and heroin use [methadone, buprenorphine and naltrexone (117)]. A variety of behavioral counseling and self-help programs (including 12-step programs), can also be effective independently or often as adjuncts for these medication-assisted treatments.
The use of a harm reduction approach with substance users has increased in acceptance in the health arena, moving the focus of care from abstinence only to reducing the negative consequences of substance abuse. Harm reduction is consistent with the ethical codes for health care providers, which require respect for patients and use of evidence-based care, and has been found to help patients adopt healthy behaviors (118). For OPLWH, harm reduction efforts include assisting patients who wish to access treatment (HIV and substance use) and respecting patients' choices to continue substance use, e.g., for those who engage in drug injection, referring them to syringe exchange programs.
Training/Continuing Education Needs for Staff in Facilities with OPLWH
As the population of OPLWH grows, there is rising concern that their care providers, and care facilities for them (e.g., assisted living, geriatric care and long-term skilled nursing facilities), are not ready to provide needed services related to substance use. Recommendations for continuing education and training for health care providers treating OPLWH are listed below, and many of these can be incorporated in continuing education and graduate and undergraduate programs for clinicians planning to work with this population. Guidelines for the management of OPLWH are available (www.HIV-Age.org), and should be consulted in developing continuing education programs. Education recommendations include:
Training Programs on Beliefs About HIV, Sexual Minorities, and Substance Users
Both professional and non-professional care providers may hold stigmatizing attitudes and training should target myths or stigma that may be associated with the OPLWH. Sexual minority men, other persons with non- traditional gender identities, and those who use substances may fear being stigmatized, which can interfere with effective communication. Staff training in such techniques as motivational Interviewing and substance use counseling can also be helpful in understanding the basis for continued substance use (e.g., peer influences and depression), and provide tools for engaging clients.
Information on Ethical and Legal Obligations to Provide Care, Advocacy, and Support Services (119)
Ethical and legal guidelines for health care providers apply to accommodations in assisted living, nursing and long term care facilities. While facilities are required to post and adhere to Patients' Bill of Rights [e.g., (120)], enhancing staff skills in applying these to advocacy and care delivery may be needed. For example, training on patients' participation in their own care planning is paramount for ethical care delivery.
Information on Newer HIV-Related Treatments and Care Interventions (e.g., ART Regimens, Pre-exposure Prophylaxis [PrEP] for HIV-Negative Sexual Partners)
As treatment has been centered in HIV/AIDS dedicated centers, providers in care facilities for older populations, not specializing in this area, may need to expand their knowledge in treating this population, including education about new treatment developments.
Use of Multidisciplinary, Holistic Approaches to Care, Including Patient-Centered Care
These approaches may not be prevalent in long-term care facilities, but continue to be identified as most effective in reorienting health care models and reforming health systems. Appreciation for minority race/ethnic and cultural differences in perceptions of health care services can also serve to enhance patient-centered care.
Use of a Care Management Model
Comprehensive care with the integration of behavioral and other medical treatment provided by practitioners of multiple disciplines is now advocated in all care settings. Given the complexity of circumstances and comorbidities faced by many substance users, best practice suggests that long term care facilities and ambulatory clinics caring for older adults would be best served by embracing the “care manager” or “case manager” approach to coordinate professional and non-professional providers, and link clients to social services within communities.
Education on the Management of Co-morbidities
The prevalence of many co- morbidities in this population, with the possibility for interactions of medications, and adverse reactions to prescribed medications, requires training for staff, particularly for managing medications for OPLWH who are using alcohol, cocaine or other substances.
Education on Evidence-Based Treatment and Best Practices for Substance Use Disorders
The last decade has led to the expanded use of Medication Assisted Treatment (MAT) for opioid treatment, and harm reduction approaches. Practitioners in general health care or geriatric care may be unaware of new biomedical or behavioral treatment models for people who use substances. It has been reported that some nursing facilities refuse to admit patients if they are taking medication to treat opioid addiction (121). Problems emerging around this may be due to gaps in staff training, and persistence in the erroneous belief that 12 step models requiring abstinence, because of their dominance, are the gold standard for addiction treatment. Knowledge of these changes and support for MAT can help OPLWH find suitable program placements (122).
Limitations and Conclusions
It should be noted that while broad in scope, this paper has several limitations. It was developed to identify key issues that should be considered in providing care to substance -using OPLWH. As such, it does not provide a comprehensive review of the literature. In addition, while some of the recommendations are practiced in many clinical settings (e.g., screening for substance use and referral for drug treatment) they are often not widely implemented across patient groups, especially OPLWH and those entering geriatric care facilities.
As the population of OPLWH continues to increase, clinicians working with those who are substance users will need to address a broad range of issues. For OPLWH, especially those who have been or are currently substance users, care management must go beyond a focus on viral suppression. Integrated care to address their treatment needs, with the contributions of multiple professional disciplines and health care specialties, will be needed to maximize health outcomes for this population. Furthermore, in addition to addressing the individual needs of OPLWH, structural barriers to the delivery of needed health care services must also be addressed, including availability of drug treatment and harm reduction services, as well as social conditions that impact their health (e.g., homelessness).
Author Contributions
SD conceived of the paper and drafted sections. TC, VD, VG-R, BH, SK, MN, DO, and BW wrote sections of the paper. All authors reviewed the final manuscript.
Funding
This research was supported by funds from the National Institute on Drug Abuse (P30DA011041, Deren & Hagan). The content is the sole responsibility of the authors and does not necessarily represent the official views of the NIH or any of the institutions involved in this research.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The authors would also like to thank the journal reviewers of an earlier version of this manuscript for their helpful suggestions.
References
1. Centers for Disease Control and Prevention. HIV Among People Aged 50 and Over. (2018). Available online at: https://www.cdc.gov/hiv/group/age/olderamericans/index.html (accessed May 1, 2018).
2. Centers for Disease Control and Prevention. HIV Surveillance Report, 2016. (2017). Available online at: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html (accessed January 27, 2018).
3. Ghidei L, Simone MJ, Salow MJ, Zimmerman KM, Paquin AM, Skarf LM, et al. Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging. (2013) 30:809–19. doi: 10.1007/s40266-013-0107-7
4. Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis. (2013) 57:1309–17. doi: 10.1093/cid/cit427
5. Edelman EJ, Tetrault JM, Fiellin DA. Substance use in older HIV-infected patients. Curr Opin HIV AIDS. (2014) 9:317–24. doi: 10.1097/COH.0000000000000069
6. Millar BM, Starks TJ, Gurung S, Parsons JT. The impact of comorbidities, depression, and substance use problems on quality of life among older adults living with HIV. AIDS Behav. (2017) 21:1684–90. doi: 10.1007/s10461-016-1613-5
7. Brennan M, Karpiak SE, Shippy A, Cantor MH. Older Adults with HIV: An In-Depth Examination of an Emerging Population. New York, NY: Nova Science Publishers, Inc. (2009).
8. Applebaum A, Brennan M. Substance and alcohol use. In: Brennan M, Karpiak S, Shippy R, Cantor M, editors. Older Adults with HIV: An In-depth Examination of an Emerging Population. New York, NY: Nova Science Publishers, Inc (2009).
9. Bensley KM, McGinnis KA, Fiellin DA, Gordon AJ, Kraemer KL, Bryant KJ, et al. Racial/ethnic differences in the association between alcohol use and mortality among men living with HIV. Addict Sci Clin Pract. (2018) 13:2. doi: 10.1186/s13722-017-0103-z
10. Parsons JT, Starks TJ, Millar BM, Boonrai K, Marcotte D. Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence. Drug Alcohol Depend. (2014) 139:33–40. doi: 10.1016/j.drugalcdep.2014.02.704
11. Centers for Disease Control and Prevention. HIV Among People Who Inject Drugs. (2018). Available online at: https://www.cdc.gov/hiv/group/hiv-idu.html (accessed June 12, 2018).
12. Cleary M, Sayers J, Bramble M, Jackson D, Lopez V. Overview of substance use and mental health among the “baby boomers” generation. Issues Ment Health Nurs. (2017) 38:61–5. doi: 10.1080/01612840.2016.1243177
13. Centers for Disease Control and Prevention. New HIV Infections in the United States. (2016). Available online at: https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/new-hiv-infections-508.pdf (accessed June 20, 2018).
14. Institute of Medicine. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington, DC: The National Academies Press (2011).
15. Bourne A, Weatherburn P. Substance use among men who have sex with men: patterns, motivations, impacts and intervention development need. Sex Transm Infect. (2017) 93:342–6. doi: 10.1136/sextrans-2016-052674
16. Kurtz SP, Stall RD, Buttram ME, Surratt HL, Chen M. A randomized trial of a behavioral intervention for high risk substance-using MSM. AIDS Behav. (2013) 17:2914–26. doi: 10.1007/s10461-013-0531-z
17. Ompad DC, Kingdon M, Kupprat S, Halkitis SN, Storholm ED, Halkitis PN. Smoking and HIV-related health issues among older HIV-positive gay, bisexual, and other men who have sex with men. Behav Med. (2014) 40:99–107. doi: 10.1080/08964289.2014.889067
18. US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2014). Available online at: https://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf (accessed December 19, 2016).
19. Kooij KW, Wit FW, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra NA, et al. Cigarette smoking and inflammation, monocyte activation, and coagulation in HIV-infected individuals receiving antiretroviral therapy, compared with uninfected individuals. J Infect Dis. (2016) 214:1817–21. doi: 10.1093/infdis/jiw459
20. Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. (2015) 162:335–44. doi: 10.7326/M14-0954
21. Shirley DK, Kaner RJ, Glesby MJ. Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clin Infect Dis. (2013) 57:275–82. doi: 10.1093/cid/cit207
22. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. (2013) 56:727–34. doi: 10.1093/cid/cis933
23. Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. AIDS Educ Prev. (2009) 21 (Suppl. 3):94–105. doi: 10.1521/aeap.2009.21.3_supp.94
24. Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol. (2003) 8:39–43. doi: 10.1080/1355621031000069864
25. Winhusen T, Feaster DJ, Duan R, Brown JL, Daar ES, Mandler R, et al. Baseline cigarette smoking status as a predictor of virologic suppression and CD4 cell count during one-year follow-up in substance users with uncontrolled HIV infection. AIDS Behav. (2018) 22:2026–32. doi: 10.1007/s10461-017-1928-x
26. Jones S, Restrepo D, Kasowitz A, Korenstein D, Wallenstein S, Schneider A, et al. Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporos Int. (2008) 19:913–8. doi: 10.1007/s00198-007-0524-8
27. Stevenson JS. Alcohol use, misuse, abuse, and dependence in later adulthood. Annu Rev Nurs Res. (2005) 23:245–80. doi: 10.1891/0739-6686.23.1.245
28. US Department of Health and Human Services, Office of the Surgeon General. Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington, DC: US Dept of Health and Human Services (2016). Available online at: https://addiction.surgeongeneral.gov/surgeon-generals-report.pdf (accessed December 20, 2016).
29. Centers for Disease Control and Prevention. Alcohol-Related Disease Impact (ARDI) Application. (2018). Available online at: https://nccd.cdc.gov/DPH_ARDI/default/default.aspx (accessed June 4, 2018).
30. Rehm J, Probst C, Shield KD, Shuper PA. Does alcohol use have a causal effect on HIV incidence and disease progression? A review of the literature and a modeling strategy for quantifying the effect. Population Health Metrics. (2017) 15:4. doi: 10.1186/s12963-017-0121-9
31. Armstrong-Moore R, Haighton C, Davinson N, Ling J. Interventions to reduce the negative effects of alcohol consumption in older adults: a systematic review. BMC Public Health. (2018) 18:302. doi: 10.1186/s12889-018-5199-x
32. Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and factors associated with hazardous alcohol use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav. (2017) 21:1914–25. doi: 10.1007/s10461-017-1740-7
33. Edelman EJ, Williams EC, Marshall BDL. Addressing unhealthy alcohol use among people living with HIV: recent advances and research directions. Curr Opin Infect Dis. (2018) 31:1–7. doi: 10.1097/QCO.0000000000000422
34. Molina PE, Simon L, Amedee AM, Welsh DA, Ferguson TF. Impact of alcohol on HIV disease pathogenesis, comorbities and aging: integrating preclinical and clinical findings. Alcohol Alcohol. (2018). doi: 10.1093/alcalc/agy016
35. Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. (2014) 59:1787–97. doi: 10.1093/cid/ciu701
36. Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review. Curr HIV/AIDS Rep. (2015) 12:421–36. doi: 10.1007/s11904-015-0285-5
37. Ogedengbe OO, Naidu ECS, Azu OO. Antiretroviral therapy and alcohol interactions: X-raying testicular and seminal parameters under the HAART era. Eur J Drug Metab Pharmacokinet. (2018) 43:121–35. doi: 10.1007/s13318-017-0438-6
38. Brown TT, Guaraldi G. Multimorbidity and burden of disease. Interdiscip Top Gerontol Geriatr. (2017) 42:59–73. doi: 10.1159/000448544
39. Maciel RA, Kluck HM, Durand M, Sprinz E. Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: a cross-sectional study. Int J Infect Dis. (2018) 70:30–5. doi: 10.1016/j.ijid.2018.02.009
40. Havlik RJ. Health status, Comorbidities, and Health-related Quality-of-Life. Older Adults with HIV: An In-depth Examination of an Emerging Population. New York, NY: Nova Science Publishers, Inc (2009).
41. Kaplan-Lewis E, Aberg JA, Lee M. Aging with HIV in the ART era. Semin Diagn Pathol. (2017) 34:384–97. doi: 10.1053/j.semdp.2017.04.002
42. Vance DE, Mugavero M, Willig J, Raper JL, Saag MS. Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care. (2011) 22:17–25. doi: 10.1016/j.jana.2010.04.002
43. Marin B, Thiebaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. (2009) 23:1743–53. doi: 10.1097/QAD.0b013e32832e9b78
44. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci. (2014) 69:833–42. doi: 10.1093/gerona/glt168
46. Martin-Iguacel R, Negredo E, Peck R, Friis-Moller N. Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV. Curr Hypertens Rep. (2016) 18:46. doi: 10.1007/s11906-016-0656-3
47. Karpiak SE, Havlik R. Are HIV-infected older adults aging differently? Interdiscip Top Gerontol Geriatr. (2017) 42:11–27. doi: 10.1159/000448539
48. Oursler KK, Goulet JL, Crystal S, Justice AC, Crothers K, Butt AA, et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the veterans aging cohort study. AIDS Patient Care STDS. (2011) 25:13–20. doi: 10.1089/apc.2010.0242
49. Siefried KJ, Mao L, Cysique LA, Rule J, Giles ML, Smith DE, et al. Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy. AIDS. (2018) 32:35–48. doi: 10.1097/QAD.0000000000001685
50. Kim TW, Walley AY, Ventura AS, Patts GJ, Heeren TC, Lerner GB, et al. Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence. AIDS Care. (2018) 30:150–9. doi: 10.1080/09540121.2017.1384532
51. Kumar S, Rao PS, Earla R, Kumar A. Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opin Drug Metab Toxicol. (2015) 11:343–55. doi: 10.1517/17425255.2015.996546
52. Clements KM, Hydery T, Tesell MA, Greenwood BC, Angelini MC. A systematic review of community-based interventions to improve oral chronic disease medication regimen adherence among individuals with substance use disorder. Drug Alcohol Depend. (2018) 188:141–52. doi: 10.1016/j.drugalcdep.2018.03.039
53. Zhang Y, Wilson TE, Adedimeji A, Merenstein D, Milam J, Cohen J, et al. The impact of substance use on adherence to antiretroviral therapy among HIV-infected women in the United States. AIDS Behav. (2018) 22:896–908. doi: 10.1007/s10461-017-1808-4
54. Cigolle CT, Langa KM, Kabeto MU, Tian Z, Blaum CS. Geriatric conditions and disability: the health and retirement study. Ann Intern Med. (2007) 147:156–64. doi: 10.7326/0003-4819-147-3-200708070-00004
55. Buurman BM, Hoogerduijn JG, de Haan RJ, Abu-Hanna A, Lagaay AM, Verhaar HJ, et al. Geriatric conditions in acutely hospitalized older patients: prevalence and one-year survival and functional decline. PLoS ONE. (2011) 6:e26951. doi: 10.1371/journal.pone.0026951
56. Boling PA, Leff B. Comprehensive longitudinal health care in the home for high-cost beneficiaries: a critical strategy for population health management. J Am Geriatr Soc. (2014) 62:1974–6. doi: 10.1111/jgs.13049
57. Counsell SR, Callahan CM, Clark DO, Tu W, Buttar AB, Stump TE, et al. Geriatric care management for low-income seniors: a randomized controlled trial. JAMA. (2007) 298:2623–33. doi: 10.1001/jama.298.22.2623
58. Greene M, Covinsky KE, Valcour V, Miao Y, Madamba J, Lampiris H, et al. Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr. (2015) 69:161–7. doi: 10.1097/QAI.0000000000000556
59. Singh HK, Del Carmen T, Freeman R, Glesby MJ, Siegler EL. From one syndrome to many: incorporating geriatric consultation into HIV care. Clin Infect Dis. (2017) 65:501–6. doi: 10.1093/cid/cix311
60. Han BH, Moore AA. Prevention and screening of unhealthy substance use by older adults. Clin Geriatr Med. (2018) 34:117–29. doi: 10.1016/j.cger.2017.08.005
61. Reece AS. Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immun Ageing. (2007) 4:6. doi: 10.1186/1742-4933-4-6
62. Chau DL, Walker V, Pai L, Cho LM. Opiates and elderly: use and side effects. Clin Interv Aging. (2008) 3:273–8. doi: 10.2147/CIA.S1847
63. Bachi K, Sierra S, Volkow ND, Goldstein RZ, Alia-Klein N. Is biological aging accelerated in drug addiction? Curr Opin Behav Sci. (2017) 13:34–9. doi: 10.1016/j.cobeha.2016.09.007
64. Negredo E, Back D, Blanco JR, Blanco J, Erlandson KM, Garolera M, et al. Aging in HIV-infected subjects: a new scenario and a new view. Biomed Res Int. (2017) 2017:5897298. doi: 10.1155/2017/5897298
65. George O, Mandyam CD, Wee S, Koob GF. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology. (2008) 33:2474–82. doi: 10.1038/sj.npp.1301626
66. Arguello AA, Harburg GC, Schonborn JR, Mandyam CD, Yamaguchi M, Eisch AJ. Time course of morphine's effects on adult hippocampal subgranular zone reveals preferential inhibition of cells in S phase of the cell cycle and a subpopulation of immature neurons. Neuroscience. (2008) 157:70–9. doi: 10.1016/j.neuroscience.2008.08.064
67. Kelley BJ, Yeager KR, Pepper TH, Beversdorf DQ. Cognitive impairment in acute cocaine withdrawal. Cogn Behav Neurol. (2005) 18:108–12. doi: 10.1097/01.wnn.0000160823.61201.20
68. Davis C, Cohen A, Davids M, Rabindranath A. Attention-deficit/hyperactivity disorder in relation to addictive behaviors: a moderated-mediation analysis of personality-risk factors and sex. Front Psychiatry. (2015) 6:47. doi: 10.3389/fpsyt.2015.00047
69. Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug Alcohol Depend. (2005) 78:225–30. doi: 10.1016/j.drugalcdep.2004.10.008
70. Gunn RL, Gerst KR, Lake AJ, Finn PR. The effects of working memory load and attention refocusing on delay discounting rates in alcohol use disorder with comorbid antisocial personality disorder. Alcohol. (2018) 66:9–14. doi: 10.1016/j.alcohol.2017.07.009
71. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav. (2005) 81:319–30. doi: 10.1016/j.pbb.2005.02.017
72. McClernon FJ, Froeliger B, Rose JE, Kozink RV, Addicott MA, Sweitzer MM, et al. The effects of nicotine and non-nicotine smoking factors on working memory and associated brain function. Addict Biol. (2016) 21:954–61. doi: 10.1111/adb.12253
73. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA. (2002) 287:1123–31. doi: 10.1001/jama.287.9.1123
74. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, et al. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology. (2003) 167:85–96. doi: 10.1007/s00213-002-1383-9
75. Verdejo-García A, Pérez-García M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology. (2007) 190:517–30. doi: 10.1007/s00213-006-0632-8
76. Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. (2008) 22 (Suppl. 2):S67–79. doi: 10.1097/01.aids.0000327438.13291.62
77. Lekas HM, Siegel K, Schrimshaw EW. Continuities and discontinuities in the experiences of felt and enacted stigma among women with HIV/AIDS. Qual Health Res. (2006) 16:1165–90. doi: 10.1177/1049732306292284
78. Emlet CA. “You're awfully old to have this disease”: experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS. Gerontologist. (2006) 46:781–90. doi: 10.1093/geront/46.6.781
79. Stein GL, Beckerman NL, Sherman PA. Lesbian and gay elders and long-term care: identifying the unique psychosocial perspectives and challenges. J Gerontol Soc Work. (2010) 53:421–35. doi: 10.1080/01634372.2010.496478
80. Johnson Shen M, Freeman R, Karpiak S, Brennan-Ing M, Seidel L, Siegler EL. The intersectionality of stigmas among key populations of older adults affected by HIV: a thematic analysis. Clin Gerontol. (2018) 42:137–49. doi: 10.1080/07317115.2018.1456500
81. Sangaramoorthy T, Jamison A, Dyer T. Intersectional stigma among midlife and older Black women living with HIV. Cult Health Sexuality. (2017) 19:1329–43. doi: 10.1080/13691058.2017.1312530
82. Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. (2016) 6:e011453. doi: 10.1136/bmjopen-2016-011453
83. Emlet CA. Stigma in an aging context. Interdiscip Top Gerontol Geriatr. (2017) 42:144–58. doi: 10.1159/000448560
84. Porter KE, Brennan-Ing M, Burr JA, Dugan E, Karpiak SE. HIV stigma and older men's psychological well-being: do coping resources differ for gay/bisexual and straight men? J Gerontol B Psychol Sci Soc Sci. (2019). 74:685–93. doi: 10.1093/geronb/gbx101
85. Afifi TO, Henriksen CA, Asmundson GJ, Sareen J. Childhood maltreatment and substance use disorders among men and women in a nationally representative sample. Can J Psychiatry. (2012) 57:677–86. doi: 10.1177/070674371205701105
86. Wilson HW, Widom CS. An examination of risky sexual behavior and HIV in victims of child abuse and neglect: a 30-year follow-up. Health Psychol. (2008) 27:149–58. doi: 10.1037/0278-6133.27.2.149
87. Lee JG, Henriksen L, Rose SW, Moreland-Russell S, Ribisl KM. A systematic review of neighborhood disparities in point-of-sale tobacco marketing. Am J Public Health. (2015) 105:e8–18. doi: 10.2105/AJPH.2015.302777
88. Mereish EH, Goldbach JT, Burgess C, DiBello AM. Sexual orientation, minority stress, social norms, and substance use among racially diverse adolescents. Drug Alcohol Depend. (2017) 178:49–56. doi: 10.1016/j.drugalcdep.2017.04.013
89. Lopez-Patton M, Kumar M, Jones D, Fonseca M, Kumar AM, Nemeroff CB. Childhood trauma and METH abuse among men who have sex with men: implications for intervention. J Psychiatr Res. (2016) 72:1–5. doi: 10.1016/j.jpsychires.2015.09.009
90. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. (2007) 357:762–74. doi: 10.1056/NEJMoa067423
91. Golub SA, Grov C, Tomassilli J. Sexual behavior among HIV+ older adults. In: Brennan M, Karpiak SE, Shippy RA, Cantor MH, editors. Older Adults with HIV: An In-depth Examination of an Emerging Population. New York, NY: Nova Science Publishers, Inc (2009). p. 43–50.
92. Taylor TN, Munoz-Plaza CE, Goparaju L, Martinez O, Holman S, Minkoff HL, et al. “The pleasure is better as I've gotten older”: sexual health, sexuality, and sexual risk behaviors among older women living with HIV. Arch Sex Behav. (2017) 46:1137–50. doi: 10.1007/s10508-016-0751-1
93. Kupprat SA, Krause KD, Ompad DC, Halkitis PN. Substance use and cognitive function as drivers of condomless anal sex among HIV-positive gay, bisexual, and other men who have sex with men aged 50 and older: the gold studies. LGBT Health. (2017) 4:434–41. doi: 10.1089/lgbt.2016.0163
94. Hutton HE, McCaul ME, Chander G, Jenckes MW, Nollen C, Sharp VL, et al. Alcohol use, anal sex, and other risky sexual behaviors among HIV-infected women and men. AIDS Behav. (2013) 17:1694–704. doi: 10.1007/s10461-012-0191-4
95. Starks TJ, Millar BM, Parsons JT. Predictors of condom use with main and casual partners among HIV-positive men over 50. Health Psychol. (2015) 34:1116–22. doi: 10.1037/hea0000236
96. Karpiak SE, Lunievicz JL. Age is not a condom: HIV and sexual health for older adults. Curr Sex Health Rep. (2017) 9:109–15. doi: 10.1007/s11930-017-0119-0
97. Golub SA, Tomassilli JC, Pantalone DW, Brennan M, Karpiak SE, Parsons JT. Prevalence and correlates of sexual behavior and risk management among HIV-positive adults over 50. Sex Transm Dis. (2010) 37:615–20. doi: 10.1097/OLQ.0b013e3181e15f20
98. Heath J, Lanoye A, Maisto SA. The role of alcohol and substance use in risky sexual behavior among older men who have sex with men: a review and critique of the current literature. AIDS Behav. (2012) 16:578–89. doi: 10.1007/s10461-011-9921-2
99. Brennan-Ing M, Porter KE, Seidel L, Karpiak SE. Substance use and sexual risk differences among older bisexual and gay men with HIV. Behav Med. (2014) 40:108–15. doi: 10.1080/08964289.2014.889069
100. De P, Farley A, Lindson N, Aveyard P. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. (2013) 11:15. doi: 10.1186/1741-7015-11-15
101. Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med. (2011) 12:412–21. doi: 10.1111/j.1468-1293.2010.00901.x
102. Calvo-Sánchez M, Martinez E. How to address smoking cessation in HIV patients. HIV Med. (2015) 16:201–10. doi: 10.1111/hiv.12193
103. Ledgerwood DM, Yskes R. Smoking cessation for people living with HIV/AIDS: a literature review and synthesis. Nicotine Tob Res. (2016) 18:2177–84. doi: 10.1093/ntr/ntw126
104. US Preventive Services Task Force. Final Update Summary: Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care. (2016). Available online at: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care (accessed December 15, 2016).
105. National Institute on Alcohol Abuse and Alcoholism. Drinking Levels Defined. (2018). Available online at: https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking (accessed July 10, 2018).
106. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. (2009) 99:280–95. doi: 10.1016/j.drugalcdep.2008.08.003
107. Institute of Medicine. The Future of Nursing: Leading Change, Advancing Health. Washington, DC: The National Academies Press (2011).
108. Deren S, Naegle M, Hagan H, Ompad DC. Continuing links between substance use and HIV highlight the importance of nursing roles. J Assoc Nurses AIDS Care. (2017) 28:622–32. doi: 10.1016/j.jana.2017.03.005
109. Rodda J, Walker Z, Carter J. Depression in older adults. BMJ. (2011) 343:d5219. doi: 10.1136/bmj.d5219
110. Cahoon CG. Depression in older adults. Am J Nurs. (2012) 112:22–30. doi: 10.1097/01.NAJ.0000422251.65212.4b
111. American Psychological Association. Patient Health Questionnaire (PHQ-9 & PHQ-2). (2018). Available online at: http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/patient-health.aspx (accessed September 10, 2018).
112. Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. (2010) 8:348–53. doi: 10.1370/afm.1139
113. Doerflinger D. Mental Status Assessment in Older Adults: Montreal Cognitive Assessment MoCA Version 7.1 (Original Version). (2012). Available online at: https://consultgeri.org/try-this/general-assessment/issue-3.2.pdf (accessed August 10, 2018).
114. Ports KA, Barnack-Tavlaris JL, Syme ML, Perera RA, Lafata JE. Sexual health discussions with older adult patients during periodic health exams. J Sex Med. (2014) 11:901–8. doi: 10.1111/jsm.12448
115. Centers for Disease Control and Prevention. Quitting Smoking. (2017). Available online at: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm (accessed August 29, 2018).
116. National Institute on Alcohol Abuse and Alcoholism. Treatment for Alcohol Problems: Finding and Getting Help. (2014). Available online at: https://pubs.niaaa.nih.gov/publications/treatment/treatment.htm (accessed June 20, 2018).
117. National Institute on Drug Abuse. Effective Treatments for Opioid Addiction. (2016). Available online at: https://www.drugabuse.gov/publications/effective-treatments-opioid-addiction/effective-treatments-opioid-addiction (accessed August 10, 2018).
118. Bartlett R, Brown L, Shattell M, Wright T, Lewallen L. Harm reduction: compassionate care of persons with addictions. Medsurg Nurs. (2013) 22:349–53.
119. Lambda Legal. Long-Term Care and People Living with HIV. (2010). Available online at: https://www.lambdalegal.org/sites/default/files/publications/downloads/fs_long-term-care-and-people-living-with-hiv_1.pdf (accessed August 10, 2018).
120. New York State Department of Health. New York State Hospital Patients' Bill of Rights. (2017). Available online at: https://www.health.ny.gov/publications/1500/ (accessed June 17, 2018).
121. Bond A. Nursing Homes Routinely Refuse People on Addiction Treatment—Which Some Experts Say is Illegal. (2018). Available online at: https://www.statnews.com/2018/04/17/nursing-homes-addiction-treatment/ (accessed May 4, 2018).
Keywords: aging, HIV, substance use, alcohol, smoking, comorbidities
Citation: Deren S, Cortes T, Dickson VV, Guilamo-Ramos V, Han BH, Karpiak S, Naegle M, Ompad DC and Wu B (2019) Substance Use Among Older People Living With HIV: Challenges for Health Care Providers. Front. Public Health 7:94. doi: 10.3389/fpubh.2019.00094
Received: 10 December 2018; Accepted: 04 April 2019;
Published: 24 April 2019.
Edited by:
William Edson Aaronson, Temple University, United StatesReviewed by:
Brett Millar, Hunter College (City University of New York), United StatesCaroline Diane Bergeron, Bexar County Community Health Collaborative, United States
Copyright © 2019 Deren, Cortes, Dickson, Guilamo-Ramos, Han, Karpiak, Naegle, Ompad and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sherry Deren, shd2@nyu.edu